|
|
TGF-β1 up-regulates expression of ABCA1,ABCG1 and SR-BI through liver X receptor α signaling pathway in THP-1 macrophage-derived foam cells
|
|
|
|
|
نویسنده
|
hu y.-w. ,wang q. ,ma x. ,li x.-x. ,liu x.-h. ,xiao j. ,liao d.-f. ,xiang j. ,tang c.-k.
|
منبع
|
journal of atherosclerosis and thrombosis - 2010 - دوره : 17 - شماره : 5 - صفحه:493 -502
|
چکیده
|
Aim: high density lipoprotein (hdl) and its apolipoproteins can promote cholesterol efflux from macrophage foam cells via the atp-binding cassette transporter a1 (abca1),abcg1,and scavenger receptor class b type i (sr-bi). liver x receptors (lxrs) operate as cholesterol sensors which may protect from cholesterol overload by stimulating cholesterol efflux from cells to hdl through abca1,abcg1 and sr-bi. the regulation of abca1,abcg1 and sr-bi expression by cytokines present within the microenvironment of the atheroma may play an important role in determining the impact of reverse cholesterol transport on the atherosclerotic lesion. in the current study,we examined the effect of transforming growth factor-β1 (tgf-β1) on expressions of abca1,abcg1 and sr-bi and explored the role of lxr α in the regulation of abca1,abcg1 and sr bi in thp-1 macrophage-derived foam cells. methods and results: tgf-kj{cyrillic}1 significantly increased expressions of abca1,abcg1 and sr-bi at both transcriptional and translational levels in a dose-dependent and time-dependent manner. cellular cholesterol content was decreased while cholesterol efflux was increased by tgf-β1 treatment. moreover,lxr α was up regulated by tgf-β1 treatment. in addition,lxr α small interfering rna completely abolished the promotion effect induced by tgf-β1. conclusion: these results provide evidence that tgf-β1 up-regulates expressions of abca1,abcg1 and sr-bi through the lxr α pathway in thp-1 macrophage-derived foam cells.
|
کلیدواژه
|
Abca1; Abcg1; Atherosclerosis; Lxr α; Sr-bi; Tgf-β1
|
آدرس
|
institute of cardiovascular research,key laboratory for atherosclerology of hunan province,life science research center,university of south china,china,laboratory medicine center,nangfang hospital,southern medical university, China, laboratory medicine center,nangfang hospital,southern medical university, China, department of anesthesiology,the first affiliated hospital of university of south china, China, institute of cardiovascular research,key laboratory for atherosclerology of hunan province,life science research center,university of south china, China, institute of cardiovascular research,key laboratory for atherosclerology of hunan province,life science research center,university of south china, China, institute of cardiovascular research,key laboratory for atherosclerology of hunan province,life science research center,university of south china, China, institute of pharmacy and pharmacology,life science research center,university of south china, China, research unit,health research division,saskatchewan cancer agency,department of oncology,university of saskatchewan, Canada, institute of cardiovascular research,key laboratory for atherosclerology of hunan province,life science research center,university of south china, China
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|